Crispr'd Cells Show Promise in First US Human Safety Trial
It\u2019s been over three years since US regulators greenlit the nation\u2019s first in-human test of Crispr\u2019s disease-fighting potential, more than three years of waiting to find out if the much-hyped gene-editing technique could be safely used to beat back tough-to-treat cancers. Today, researchers from the University of Pennsylvania and Stanford finally revealed the first published report describing the trial.